Directory
Antonia Salud Salvia

Antonia Salud Salvia

Degree: PhD


masalud.lleida.ics(ELIMINAR)@gencat.cat

Groups

Publications

  • Márquez-Medina D; Gasol-Cudós A; Taberner-Bonastre MT; Samamé Pérez-Vargas JC; Salud-Salvia A; Llombart-Cussac A

    Human Papillomavirus in Non-Small-Cell Lung Cancer: The Impact of EGFR Mutations and the Response to Erlotinib

    ARCHIVOS DE BRONCONEUMOLOGIA 49 79-81. .

    [doi:10.1016/j.arbres.2012.04.003]

  • Bennouna J; Sastre J; Arnold D; Österlund P; Greil R; Van Cutsem E; von Moos R; Viéitez JM; Bouché O; Borg C; Steffens CC; Alonso-Orduña V; Schlichting C; Reyes-Rivera I; Bendahmane B; André T; Kubicka S

    Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

    LANCET ONCOLOGY 14 29-37. .

    [doi:10.1016/S1470-2045(12)70477-1]

  • Muñoz A; Pericay C; García-Girón C; Alonso V; Dueñas R; Cirera L; Rivera F; Falcó E; Bustos IA; Salud A

    Phase II Study of Bevacizumab, Capecitabine, and Oxaliplatin Followed by Bevacizumab Plus Erlotinib as First-Line Therapy in Metastatic Colorectal Cancer

    ONCOLOGY RESEARCH 21 181-191. .

    [doi:10.3727/096504014X13887748696743]

  • Marquez-Medina, Diego; Salla-Fortuny, Joel; Salud-Salvia, Antonieta

    Role of gamma-delta T-cells in cancer. Another opening door to immunotherapy

    CLINICAL & TRANSLATIONAL ONCOLOGY 14 891-895. .

    [doi:10.1007/s12094-012-0935-7]

  • Gravalos, Cristina; Salut, Antonieta; Garcia-Giron, Carlos; Garcia-Carbonero, Rocio; Isabel Leon, Ana; Sevilla, Isabel; Maurel, Joan; Esteban, Beatriz; Garcia-Rico, Eduardo; Murias, Adolfo; Cortes-Funes, Hernan

    A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer

    CLINICAL & TRANSLATIONAL ONCOLOGY 14 606-612. .

    [doi:10.1007/s12094-012-0843-x]

  • Anton, A.; Montalar, J.; Carulla, J.; Jara, C.; Batista, N.; Camps, C.; Cassinello, J.; Sanz-Ortiz, J.; Diaz-Rubio, E.; Martinez, C.; Ledesma, F.; Zubillaga, E.; ALGOS Grp; DOME III Study Grp

    Pain in clinical oncology: Patient satisfaction with management of cancer pain

    EUROPEAN JOURNAL OF PAIN 16 381-389. .

    [doi:10.1002/j.1532-2149.2011.00036.x]

  • Maria Vieitez, Jose; Garcia-Carbonero, Rocio; Aparicio, Jorge; Feliu, Jaime; Gonzalez-Flores, Encarnacion; Grande, Enrique; Perez-Hoyos, Teresa; Salud, Antonieta; Torres, Esperanza; Valero, Maria; Valladares-Ayerbes, Manuel; Diaz-Rubio, Eduardo

    Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain.

    CLINICAL & TRANSLATIONAL ONCOLOGY 13 798-804. .

    [doi:10.1007/s12094-011-0736-4]

  • Nogue, Miguel; Salud, Antonieta; Vicente, Pilar; Arrivi, Antonio; Maria Roca, Jose; Losa, Ferran; Ponce, Jose; Jose Safont, Maria; Guasch, Inmaculada; Moreno, Isabel; Ruiz, Ana; Pericay, Carles

    Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.

    Oncologist 16 614-620. .

    [doi:10.1634/theoncologist.2010-0285]

  • Bielsa, Silvia; Hernandez, Paula; Rodriguez-Panadero, Francisco; Taberner, Teresa; Salud, Antonieta; Porcel, Jose M.

    Tumor type influences the effectiveness of pleurodesis in malignant effusions.

    Lung 189 151-155. .

    [doi:10.1007/s00408-011-9283-6]

  • Feliu, J.; Safont, M. J.; Salud, A.; Losa, F.; Garcia-Giron, C.; Bosch, C.; Escudero, P.; Lopez, R.; Madronal, C.; Bolanos, M.; Gil, M.; Llombart, A.; Castro-Carpeno, J.; Gonzalez-Baron, M.

    Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.

    BRITISH JOURNAL OF CANCER 102 1468-1473. .

    [doi:10.1038/sj.bjc.6605663]

  • Fernandez-Martos, Carlos; Pericay, Carles; Aparicio, Jorge; Salud, Antonieta; Safont, MariaJose; Massuti, Bertomeu; Vera, Ruth; Escudero, Pilar; Maurel, Joan; Marcuello, Eugenio; Luis Mengual, Jose; Saigi, Eugenio; Estevan, Rafael; Mira, Moises; Polo, Sonia; Hernandez, Ana; Gallen, Manuel; Arias, Fernando; Serra, Javier; Alonso, Vicente

    Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.

    Journal of Clinical Oncology 28 859-865. .

    [doi:10.1200/JCO.2009.25.8541]

  • Roca, Jose-Maria; Alonso, Vicente; Pericay, Carles; Escudero, Pilar; Salud, Antonieta; Losa, Ferran; Lopez, Luis-Jesus; Guasch, Imma; Mendez, Miguel; Quintero-Aldana, Guillermo; Grande, Carlos; Vicente, Pilar; Arrivi, Antonio; Martin, Cristina; Moreno, Isabel; Garcia, Pilar; Anton, Isabel; Constenla, Manuel; Yubero, Alfonso; Cirera, Luis; ACROSS Cooperative Grp

    Cetuximab Given Every 2 Weeks plus Irinotecan Is an active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer

    Chemotherapy 56 142-146. .

    [doi:10.1159/000313527]

Projects

  • Decodificación de la metástasis del cáncer colorrectal desentrañando el señalosoma de PLA2G12A
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Predicción de micrometástasis en pacientes con cáncer de colon localizado de alto riesgo
  • Dimerizaciones de HER2 como elemento de decición en la terapia dirigida anti-HER2 frente al cáncer de mama
  • UTILITAT PRONOSTICA DELS PERFILS D'EXPRESSIO PROTEICA EN PACIENTS AMB TUMOR RESIDUAL VIABLE (>1.0 CM) DESPRES DE LA QUIMIOTERAPIA NEOADJUVANT EN CANCER DE MAMA
  • Cáncer de mama: utilidad pronóstica de los Perfiles de Expresión Proteica en pacientes con tumor residual viable (>1.0 cm) tras quimioterapia neoadyuvante